TERT and glioma: Reactivation of telomerase reverse transcriptase via pTERT alterations plays a pivotal role in gliomas, with pTERT mutations found in 80–90%, correlating with higher TERT mRNA and protein expression and subsequent increased telomerase activity [16,25].